India suspends drugmaker’s licence over tainted syrup

Published July 26, 2023
Logo of Marion Biotech, a healthcare and pharmaceutical company is seen on a gate outside their office in Noida, India on December 29, 2022. — Reuters
Logo of Marion Biotech, a healthcare and pharmaceutical company is seen on a gate outside their office in Noida, India on December 29, 2022. — Reuters

NEW DELHI: India has suspended a drugmaker’s manufacturing licence after the World Health Organisation flagged contamination in its cough syrups found in the Mashall Islands and Micronesia in April, the government told the parliament on Tuesday.

Indian regulators are inspecting drugmakers after cough syrups made in the country were linked to at least 89 child deaths in Gambia and Uzbekistan last year, which has damaged India’s image as the “pharmacy of the world” providing affordable drugs globally.

The WHO flagged contamination with unacceptable amounts of diethylene glycol and ethylene glycol, which are toxic to humans when consumed and can prove fatal, in samples taken from a batch of cough syrup made by QP Pharmachem Ltd, based in the northern Punjab state.

The company has denied any wrongdoing and said it planned to appeal against the suspension.

“Drug samples drawn from the manufacturing premises … were declared as ‘not of standard quality’,” Deputy Health Minister Bharati Pravin Pawar told the parliament.

The manufacturing licences of QP Pharmachem Ltd and two other companies, whose products were linked to the child deaths — Maiden Pharmaceuticals and Marion Biotech Pvt. Ltd — have been suspended and their exports halted, Pawar added.

Maiden Pharmaceuticals and Marion Biotech have also denied any wrongdoing.

Sudhir Pathak, managing director of QP Pharmachem, who said the company has planned to appeal against the suspension order with the government, said production had been halted.

Pathak said he had tested the ingredients used in the cough syrup, named Guaifenesin TG, before starting its production.

Published in Dawn, July 26th, 2023

Opinion

Editorial

Security lapses
Updated 13 Apr, 2024

Security lapses

Ensuring the safety of foreign citizens is paramount, not just for diplomatic relations but for our economic future.
An eventful season
13 Apr, 2024

An eventful season

THE Senate chairman and deputy chairman were elected unopposed, and 41 new senators were sworn in on Tuesday,...
Living rough
13 Apr, 2024

Living rough

WE either don’t see them or don’t want to see them — not even when they are actively trying to get our...
Saudi investment
Updated 10 Apr, 2024

Saudi investment

The state has to address barriers that stand in the way of attracting foreign investment, and create a pro-business environment.
Charity for change
Updated 11 Apr, 2024

Charity for change

PAKISTANIS are large-hearted people who empty their pockets at the slightest hint of another’s need. The Stanford...